Related Experiment Video
Updated: Aug 13, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells
Takanori Shouda1, Koji Hiraoka, Setsuro Komiya
1Department of Orthopedic Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
Abstract:
There is no established optimum treatment for malignant fibrous histiocytoma (MFH) at present, and few MFH cell lines are established. In the present study, we established new MFH cell lines, KHZ-MFH and SFT85-03, and investigated the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. We found that MFH cells secreted high levels of IL-6 and that STAT3 was constitutively activated in these cells. The JAK2 kinase inhibitor, tyrphostin AG490, suppressed the growth of MFH cells and inhibited the secretion of IL-6. Furthermore, blockade of activated STAT3 by forced expression of a cytokine signaling repressor, SOCS3 gene as well as a dominant-negative STAT3 in these cells significantly suppressed their growth. These results indicated that an autocrine mechanism of the JAK/STAT3 signaling pathway could promote the growth of MFH cells and that this pathway could be a therapeutic target of MFH.
Insights
New malignant fibrous histiocytoma (MFH) cell lines were developed and studied. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway was found to drive MFH cell growth, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant fibrous histiocytoma (MFH) lacks an established optimal treatment.
- Limited availability of MFH cell lines hinders research.
Purpose of the Study:
- To establish new MFH cell lines.
- To investigate the role of the JAK/STAT signaling pathway in MFH.
- To explore potential therapeutic targets for MFH.
Main Methods:
- Establishment of KHZ-MFH and SFT85-03 cell lines.
- Analysis of the JAK/STAT signaling pathway components and activity.
- Inhibition of JAK2 kinase with tyrphostin AG490.
- Blockade of STAT3 activation using SOCS3 gene and dominant-negative STAT3.
Main Results:
- MFH cells exhibited high IL-6 secretion and constitutive STAT3 activation.
- JAK2 inhibition suppressed MFH cell growth and IL-6 secretion.
- STAT3 blockade significantly inhibited MFH cell proliferation.
Conclusions:
- An autocrine JAK/STAT3 signaling loop promotes MFH cell growth.
- The JAK/STAT3 pathway represents a potential therapeutic target for MFH treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
Abnormal Proliferation
The Tumor Microenvironment
